EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2

por Gómez-Benito, M, Conchillo, A, García, M A, Vázquez, I, Maicas, M, Vicente, C, Cristobal, I, Marcotegui, N, García-Ortí, L, Bandrés, E, Calasanz, M J, Alonso, M M, Odero, M D
Publicado 2010

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression

por Pellagatti, A, Roy, S, Di Genua, C, Burns, A, McGraw, K, Valletta, S, Larrayoz, M J, Fernandez-Mercado, M, Mason, J, Killick, S, Mecucci, C, Calasanz, M J, List, A, Schuh, A, Boultwood, J
Publicado 2016

The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia

por Rio-Machin, A, Gómez-López, G, Muñoz, J, Garcia-Martinez, F, Maiques-Diaz, A, Alvarez, S, Salgado, R N, Shrestha, M, Torres-Ruiz, R, Haferlach, C, Larráyoz, M J, Calasanz, M J, Fitzgibbon, J, Cigudosa, J C
Publicado 2017

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion

por Castillo, Martín I., Ribate, Villamón E., Muñoz, Calabuig M., Santillana, Sanz G., Taboada, Such E., Casterá, Mora E., Abinzano, Calasanz M. J., Barranco, Irigoyen A., Nieto, Collado R., Pampliega, Vara M., Blanco, M. L., de Andrés, Álvarez S., de Oteyza, Pérez J., del Castillo, Bernal T., Font, Granada I., Cayuela, Jerez A., Díez‐Campelo, M., Sánchez, Abellán R., Vercet, Solano C., Díaz, Tormo M.
Publicado 2023

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

por McGraw, K L, Zhang, L M, Rollison, D E, Basiorka, A A, Fulp, W, Rawal, B, Jerez, A, Billingsley, D L, Lin, H-Y, Kurtin, S E, Yoder, S, Zhang, Y, Guinta, K, Mallo, M, Solé, F, Calasanz, M J, Cervera, J, Such, E, González, T, Nevill, T J, Haferlach, T, Smith, A E, Kulasekararaj, A, Mufti, G, Karsan, A, Maciejewski, J P, Sokol, L, Epling-Burnette, P K, Wei, S, List, A F
Publicado 2015